Life Sciences & Medicine

Activities

Activities per year 1884 2001 2024

• 2474 Participation in conference
• 1506 Publication peer-review
• 768 Types of External academic engagement - Membership of external research organisation
• 582 Editorial activity
• 2686 More
  • 517 Types of External academic engagement - Contribution to the work of national or international committees and working groups
  • 394 Types of Public engagement and outreach - Media article or participation
  • 269 Types of External academic engagement - Membership of peer review panel or committee
  • 256 Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
  • 237 Invited talk
  • 231 Types of External academic engagement - Invited talk
  • 161 Participation in workshop, seminar, course
  • 88 Types of External academic engagement - Research and Teaching at External Organisation
  • 85 Oral presentation
  • 77 Membership of committee
  • 68 Types of Public engagement and outreach - Public lecture/debate/seminar
  • 37 Types of Public engagement and outreach - Schools engagement
  • 35 Membership of board
  • 33 Types of Award - Fellowship awarded competitively
  • 24 Types of Public engagement and outreach - Festival/Exhibition
  • 23 Membership of network
  • 21 Examination
  • 18 Types of Award - Prize (including medals and awards)
  • 16 Types of Award - Other distinction
  • 14 Types of Business and Community - Membership of public/government advisory/policy group or panel
  • 13 Types of Business and Community - Other
  • 13 Other
  • 12 Types of Public engagement and outreach - Work on advisory panels for social community and cultural engagement
  • 9 Types of External academic engagement - Hosting an academic visitor
  • 7 Visiting an external academic institution
  • 6 Hosting an academic visitor
  • 5 Membership of council
  • 4 Consultancy
  • 4 Types of Business and Community - CPD delivery/organisation of courses for externals (in kind)
  • 3 Types of Award - Appointment
  • 2 Types of Award - Election to learned society
  • 2 Types of Award - Honorary degree
  • 1 Types of Business and Community - Consultancy (in kind)
  • 1 Types of Business and Community - Hosting of external, non-academic visitor

Activities per year

Search results

• Role of VEGF-C and D inhibition in AMD

  Jackson, T. (Invited speaker)

  20 Sept 2024

  Activity: Talk or presentation › Oral presentation

• Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial

  Jackson, T. (Invited speaker)

  19 Sept 2024

  Activity: Talk or presentation › Oral presentation

• VEGF-A/-C/-D inhibition with sozinibercept and ranibizumab combination therapy for nAMD: subgroup analysis of a phase 2b study to assess the angiographic predictors of response

  Jackson, T. (Speaker)

  19 Sept 2024

  Activity: Talk or presentation › Oral presentation

• Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial

  Jackson, T. (Speaker)

  15 Sept 2024

  Activity: Talk or presentation › Oral presentation

• Eating on the Night Shift: What is important to UK night workers when designing nutritional research?

  Gibson, R. (Speaker)

  26 Mar 2024

  Activity: Talk or presentation › Oral presentation

• How are hospitals in England caring for women at risk of preterm birth in light of Saving Babies Lives Care Bundle v2 Element 5, and can we develop the midwife role here?

  Carlisle, N. (Speaker)

  28 Mar 2023

  Activity: Talk or presentation › Oral presentation

• Linkage Disequilibrium score IMPutation (LD-IMP) and LDSC++: new methods to enable more powerful multivariate GWAS analyses

  Källberg Zvrskovec, J. (Speaker)

  7 Mar 2023

  Activity: Talk or presentation › Oral presentation

• How to build this attribute in students?

  Mehta, K. (Speaker)

  23 Feb 2023 → 24 Feb 2023

  Activity: Talk or presentation › Oral presentation

• Designing, executing and interpreting randomised clinical trials

  Jackson, T. (Invited speaker)

  2 Sept 2022

  Activity: Talk or presentation › Oral presentation

• Results of Part A of KALAHARI, a Phase 2 Trial of THR-149, a plasma kallikrein inhibitor, for the treatment of diabetic macular oedema

  Jackson, T. (Speaker)

  2 Sept 2022

  Activity: Talk or presentation › Oral presentation

• Effect of sleep and mood on learning: An analysis of literature

  Mehta, K. (Speaker)

  20 Jun 2022 → 30 Jun 2022

  Activity: Talk or presentation › Oral presentation

• A factor that affects learning & performance

  Mehta, K. (Speaker)

  13 Jun 2022 → 16 Jun 2022

  Activity: Talk or presentation › Oral presentation

• Factors that affect learning and performance

  Mehta, K. (Speaker)

  8 Jun 2022

  Activity: Talk or presentation › Oral presentation

• Sleep affects learning and performance

  Mehta, K. (Speaker)

  4 May 2022

  Activity: Talk or presentation › Oral presentation

• How are hospitals in England caring for women at risk of preterm birth? The influence of national guidance on preterm birth care in England

  Carlisle, N. (Speaker)

  15 Nov 2021

  Activity: Talk or presentation › Oral presentation

• Caring for women who arrive in threatened preterm labor

  Carlisle, N. (Speaker)

  24 May 2021

  Activity: Talk or presentation › Oral presentation

• Identification of splice variants of human Nop-7-associated 2 (NSA2) and their potential role in diabetic nephropathy

  Zhang, M. (Speaker)

  21 May 2021

  Activity: Talk or presentation › Oral presentation

• Development and implementation of hypertension in pregnancy decision aids

  Chappell, L. (Speaker)

  Nov 2020

  Activity: Talk or presentation › Oral presentation

• Placental magnetic resonance imaging in pre-eclampsia

  Chappell, L. (Speaker)

  Nov 2020

  Activity: Talk or presentation › Oral presentation

• Coordinating Mental Health Act assessments

  Stevens, M. (Speaker), Martineau, S. (Speaker), Bramley, S. (Speaker), Steils, N. (Speaker) & Manthorpe, J. (Speaker)

  8 Oct 2020

  Activity: Talk or presentation › Oral presentation

• Designing, executing and interpreting randomized clinical trials

  Jackson, T. (Speaker)

  2 Oct 2020

  Activity: Talk or presentation › Oral presentation

• Placenta biomarkers in chronic kidney disease and chronic hypertension

  Chappell, L. (Speaker)

  Sept 2020

  Activity: Talk or presentation › Oral presentation

• Approaches of PET metallomics for the study of zinc trafficking in vivo

  Firth, G. (Speaker)

  26 Aug 2020

  Activity: Talk or presentation › Oral presentation

• Screening of gallium-68 labelled siderophores ​ for developing PET-imaging agents as a ​ non-invasive diagnostic tool​

  Akter, A. (Speaker)

  24 Aug 2020 → 28 Aug 2020

  Activity: Talk or presentation › Oral presentation

• Approaches of PET metallomics for the study of zinc trafficking in vivo

  Firth, G. (Speaker)

  18 Jun 2020

  Activity: Talk or presentation › Oral presentation

• Vitrectomy, subretinal TPA and gas for submacular haemorrhage due to wet AMD

  Jackson, T. (Keynote speaker)

  14 Feb 2020

  Activity: Talk or presentation › Oral presentation

• Genetic Risk of Rheumatoid Arthritis is Associated with the Oral and Gut Microbiota

  Wells, P. (Speaker)

  7 Oct 2019

  Activity: Talk or presentation › Oral presentation

• Faecal cytokine profiling provides novel insights into intestinal barrier disruption and bacterial translocation in acute decompensation of cirrhosis (Free Papers: ‘Six of the Best’)

  Patel, V. C. (Speaker)

  19 Sept 2019

  Activity: Talk or presentation › Oral presentation

• A multicentre, randomised, double-masked, sham controlled study of intravitreal OPT-302 in combination with ranibizumab, for wet AMD

  Jackson, T. (Speaker)

  15 Sept 2019

  Activity: Talk or presentation › Oral presentation

• Approaches of PET metallomics for the study of zinc trafficking in vivo

  Firth, G. (Speaker)

  5 Sept 2019

  Activity: Talk or presentation › Oral presentation

• OPT-302 Phase 2b study in wet AMD: A multicentre, randomised, double-masked, sham controlled study of intravitreal OPT-302 in combination with ranibizumab, in participants with wet AMD

  Jackson, T. (Speaker)

  5 Sept 2019

  Activity: Talk or presentation › Oral presentation

• Studying metal homeostasis in vivo with PET imaging

  Firth, G. (Speaker)

  2 Jul 2019

  Activity: Talk or presentation › Oral presentation

• Planned delivery or expectant management for late preterm pre-eclampsia

  Chappell, L. (Speaker)

  Jun 2019

  Activity: Talk or presentation › Oral presentation

• UDCA vs. placebo in women with intrahepatic cholestasis of pregnancy

  Chappell, L. (Speaker)

  Jun 2019

  Activity: Talk or presentation › Oral presentation

• Neonatal outcomes in the PHOENIX trial

  Chappell, L. (Speaker)

  Jun 2019

  Activity: Talk or presentation › Oral presentation

• Faecal cytokine profiling provides novel insights into intestinal barrier disruption and bacterial translocation in acute decompensation of cirrhosis

  Patel, V. C. (Speaker)

  29 Mar 2019

  Activity: Talk or presentation › Oral presentation

• EFFICACY OF VAGINAL CERCLAGE IN WOMEN WITH PRIOR EMERGENCY CAESAREAN SECTION

  Glazewska-Hallin, A.G.-H. (Speaker)

  15 Mar 2019

  Activity: Talk or presentation › Oral presentation

• Will she deliver preterm? Using quantitative fetal fibronectin levels to help you make clinical decisions

  Carlisle, N. (Speaker)

  28 Nov 2018 → 25 Jun 2019

  Activity: Talk or presentation › Oral presentation

• How is cancer care best provided to patients in English Prisons?

  Davies, E. (Speaker)

  31 Oct 2018

  Activity: Talk or presentation › Oral presentation

• Can common characteristics be identified as predictors for seasonal influenza vaccine uptake in pregnancy? A retrospective cohort study from a South London Hospital.

  Carlisle, N. (Speaker)

  23 Oct 2018

  Activity: Talk or presentation › Oral presentation

• Oral dysbiosis in advanced chronic liver disease

  Patel, V. C. (Speaker)

  9 Oct 2018

  Activity: Talk or presentation › Oral presentation

• Adverse perinatal outcomes in ICP and association with biochemical markers

  Chappell, L. (Speaker)

  Oct 2018

  Activity: Talk or presentation › Oral presentation

• Created of an animated film for use as a training tool for Healthcare Professionals involved in the EQUIPTT study

  Carlisle, N. (Speaker)

  14 Sept 2018

  Activity: Talk or presentation › Oral presentation

• An Audit of Threatened Preterm Labour Management across 13 Obstetric Sites

  Carlisle, N. (Speaker)

  14 Sept 2018

  Activity: Talk or presentation › Oral presentation

• INTREPID year 3 safety results

  Jackson, T. (Speaker)

  27 Jun 2018

  Activity: Talk or presentation › Oral presentation

• How do patients with malignant brain tumours experience general practice care and support? Qualitative analysis of English Cancer Patient Experience Survey data

  Davies, E. (Speaker)

  21 Jun 2018

  Activity: Talk or presentation › Oral presentation

• The alternative Mediterranean diet score and blood pressure: A cross-sectional study of US participants in the INTERMAP Study

  Gibson, R. (Speaker)

  11 Jun 2018

  Activity: Talk or presentation › Oral presentation

• Will she deliver preterm? Using quantitative fetal fibronectin levels to assess risk

  Carlisle, N. (Speaker)

  23 May 2018

  Activity: Talk or presentation › Oral presentation

• Evolution of human immune response genes

  Eriksson, A. (Speaker)

  20 Mar 2018

  Activity: Talk or presentation › Oral presentation

• The PHOENIX trial: timing of delivery in late preterm pre-eclampsia

  Chappell, L. (Speaker)

  Mar 2018

  Activity: Talk or presentation › Oral presentation